March 5, 2012 / 11:56 PM / 6 years ago

UPDATE 1-Jakks Pacific adopts poison pill to fend off Oaktree

* Adopts poison pill in response to Oaktree Capital

* Sets poison pill trigger at 10 percent

* Says rights plan will continue until March 4, 2013

March 5 (Reuters) - Jakks Pacific Inc’s board adopted a “poison pill” defense strategy against takeover overtures made by Oaktree Capital Management, saying it would trigger a rights agreement if any party bought 10 percent of its stock.

Last March, Oaktree made an unsolicited $20-a-share cash bid for Jakks. It publicly disclosed its bid in September.

Jakks later rejected Oaktree’s proposal, calling the $670 million bid “inadequate.”

Oaktree owns 5 percent of Jakks stock.

“The board adopted the rights plan in response to Oaktree Capital Management’s unsolicited and highly conditional indication of interest as well as a recent indication by Oaktree that it may accumulate additional shares of the Company’s stock in the open market,” Jakks said in a statement.

Shares of Jakks, which makes products under brands such as Pokemon, Hello Kitty and The Smurfs, closed at $15.52 on Monday on the Nasdaq, about 22 percent below Oaktree’s offer price.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below